CERE
Norges Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,335,746
| Closed | -$95.5M | – | 1919 |
|
|
2024
Q2 | $95.5M | Buy |
2,335,746
+1,610,692
| +222% | +$65.9M | 0.01% | 653 |
|
|
2024
Q1 | $30.6M | Buy |
725,054
+39,360
| +6% | +$1.66M | ﹤0.01% | 1139 |
|
|
2023
Q4 | $29.1M | Buy |
685,694
+138,723
| +25% | +$5.88M | 0.01% | 1152 |
|
|
2023
Q3 | $11.9M | Buy |
546,971
+161,259
| +42% | +$3.52M | ﹤0.01% | 1401 |
|
|
2023
Q2 | $12.3M | Sell |
385,712
-36,424
| -9% | -$1.16M | ﹤0.01% | 1454 |
|
|
2023
Q1 | $10.3M | Buy |
422,136
+247,598
| +142% | +$6.04M | ﹤0.01% | 1570 |
|
|
2022
Q4 | $5.5M | Buy |
174,538
+100,695
| +136% | +$3.18M | ﹤0.01% | 1755 |
|
|
2022
Q3 | $2.09M | Buy |
+73,843
| New | +$2.09M | ﹤0.01% | 1908 |
|
|
2021
Q3 | – | Sell |
-158,852
| Closed | -$4.07M | – | 2356 |
|
|
2021
Q2 | $4.07M | Buy |
+158,852
| New | +$4.07M | ﹤0.01% | 1934 |
|